Nothing fake about a phase 1 biotech merger into a clean shell with NASDAQ goals. People calling this a p&d just want cheap shares. No RS or dilution with 30M float. That's a formula going to dollars imo
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.